By John Ely Senior Health Reporter For Mailonline
American children who are questioned about their gender have access to a private clinic in Singapore, where the potent drugs are not administered to children.
GenderGP is run by Dr. Helen Webberley, an ex-NHS GP who describes herself as an advocate for LGBTQ+ medical rights and equality.
By establishing itself in the southeast Asian country, GenderGP has shattered any “pretense” that it cares about those rights, according to reviewers.
Her firm, which boasts of helping anyone ‘no matter how old they are’, advertises its £270 puberty-blocking injections electronically, despite campaigners calling for an immediate crackdown on ‘cowboy clinics’.
Following a landmark ruling last month, toddlers are no longer able to purchase the medicines on the NHS, forcing them to go private to obtain them.
According to health officials, there is no proof that the drugs, which stop bodily changes during menstruation like breast growth and facial hair growth, are safe or effective.
After a bomb report by professional pediatrician Dr. Hilary Cass expressed worry over their behavior, ministries have since pledged to “look properly” at enforcing a ban on private clinics.
Children will suffer and die if the recommendations from the Cass evaluation are followed, according to a defiant GenderGP in the midst of the evaluation.
GenderGP is an offshore company registered in Singapore, which doesn’t accept gay relationships.
The island country just lifted the sexual ban in 2022.
Additionally, Singapore prohibits any under-18s from obtaining mixed-sex hormones and puberty blockers, unlike the NHS.
Kids may get hormones personally from the age of 16, yet.
It is not required to register with the Care Quality Commission because of its location outside the UK.
Services like that of Dr. Webberley’s were put under the microscope by the monumental Cass evaluation on female care for children in the UK.
The withering review, led by professional pediatrician Dr. Hilary Cass, concluded that despite “remarkably poor proof” to support medical treatments like cross-sex hormones and puberty blockers, children were being set on a path of inevitable change.
In addition, Dr. Cass’ review identified secret services, finding that Satellite had been “pressurized to prescribe hormones” by people who had seen a private doctor.
The document, which covered nearly 400 sites, issued a severe warning about “the use of illegal drugs and of companies that are not regulated within the UK.”
Dr. Cass advised doctors to block personal healthcare providers from putting forth puberty blockers or hormones, especially if they are acting against the wishes of the NHS.
Unregulated private hospitals that sell puberty blockers to these kids are cashing in on their dilemma, according to LGB Alliance’s chief administrative Kate Barker.
Any pretense of “caring” is disproven by the hypocrisy of setting up a clinic in a tax haven that is actively hostile to gay rights.
Teenagers who are unsure of their gender identification can get a variety of solutions at Dr. Webberley’s GenderGP.
According to its website, it doesn’t impose a strict age criterion for evaluation and doesn’t demand parental consent.
However, it does add that until they reach a certain point in puberty, children don’t need medical care.
It uses EU-based doctors to create prescriptions for medications that are legal in the UK under a post-Brexit deal, such as puberty blockers and hormones.
This allows people, even kids, to bypass NHS guidelines on who should receive these drugs.
According to the FAQ page explaining its system, UK pharmacies are “never allowed to fail to supply” like code without “good reason.”
GenderGP claimed that babies will die if the procedures recommended are put into place in the NHS following the Cass assessment.
In a message shared by Dr. Webberley herself, it was stated that “we know children and young people will suffer and die if these recommendations are implemented.”
GenderGP continued to be a resource for all trans people of any age who are seeking gender-affirming treatment.
GenderGP described itself as being “owned by GenderGP PTE Ltd, an international organization that advocates for LGBTQI+ people all over the world,” according to GenderGP.
Its website doesn’t mention LGBT rights in the country where it is based.
Dr. Webberley is not a man to discuss; he was recently honored to learn that 70 three- and four-year-old children had been referred to the NHS for female treatment.
She was found guilty in 2018 of operating an unregistered separate medical practice and was fined £12,000.
Later in 2022, she was suspended by the Medical Practitioners Tribunal Service (MPTS) for a number of charges, including failing to deliver high-quality clinical care to three female patients who were transitioning to boys in 2016.
In its determination, the panel found 36 allegations, including failing to give enough follow-up care to a 12-year-old who was prescribed testosterone, were proved.
The MPTS imposed a two-month suspension on Dr. Webberley, but he vowed to contest the decision.
The High Court overturned the suspension a year later in 2023, finding the MPTS panel to be “confusional, clearly wrong in places, and it omitted reference to significant evidence.”
Investigations revealed that Dr. Webberley had been temporarily suspended on an interim basis since May 2017 on patient safety grounds.
Dr. Webberley was given the opportunity to continue practicing without limitations in the appeal.
The same isn’t the case for her husband, who was a former doctor, Michael Webberley.
He was removed from the UK medical register in 2022 for what an MPTS tribunal called a “catalog of failings” in relation to the seven patients who received care between February 2017 and June 2019.
One was aged just nine-years-old, with another, a teenager, killing themselves in the months that followed.
Mr. Webberley was found, with all seven patients, to have provided treatment that wasn’t clinically indicated or had been prescribed without adequate tests, examinations, or assessments.
According to the NHS, he had identified gender dysphoria, a person’s sense of unease caused by a mismatch between their biological sex and their gender identity, based on incomplete information and the failure to obtain patient informed consent.
Additionally, the tribunal determined that he had acted “aside from the limits of his expertise” as a consultant gastroenterologist and had failed to form multidisciplinary teams.
After restrictions had been placed on his wife’s practice, in a few cases, Mr. Webberley had managed to care for the patients.
The most worrying incident occurred with a 17-year-old patient who was referred to in the proceedings as “Patient W,” who contacted Mr. Webberley in 2018.
They had expressed frustration with the lengthy waiting lists for NHS treatment and stated in an email that they wanted to switch as soon as possible because it would have a “majorly positive impact” on their mental health.
“I’ve been waiting for so long to start taking hormones,” they continued, adding,” I’ve been waiting for so long.” I am so happy it is finally happening.’
Without consulting with their GP, Dr. Webberley determined that Patient W was a gender dysphoric person.
The tribunal also determined that he had prescribed testosterone when it wasn’t clinically indicated and without establishing whether the risks were lower or less severe for the patient’s physical and mental health.
Patient W had been diagnosed with Asperger’s and had’ complex’ and long-standing mental health issues but it’ did
not appear’ that Mr. Webberley was aware of them, and he’d failed to obtain the patient’s medical records, the tribunal concluded.
Just three months later, patient W committed suicide.
Dr. Webberley and GenderGP contacted MailOnline for comment.
